NO20041194L - Farmasoytiske preparater som omfatter polysakkaridkonjugater for inhibering av metastasen eller forhindring av nytt anfall av malign tumor - Google Patents

Farmasoytiske preparater som omfatter polysakkaridkonjugater for inhibering av metastasen eller forhindring av nytt anfall av malign tumor

Info

Publication number
NO20041194L
NO20041194L NO20041194A NO20041194A NO20041194L NO 20041194 L NO20041194 L NO 20041194L NO 20041194 A NO20041194 A NO 20041194A NO 20041194 A NO20041194 A NO 20041194A NO 20041194 L NO20041194 L NO 20041194L
Authority
NO
Norway
Prior art keywords
metastasis
inhibition
prevention
pharmaceutical preparations
malignant tumor
Prior art date
Application number
NO20041194A
Other languages
English (en)
Norwegian (no)
Inventor
Takayuki Kawaguchi
Satoshi Okuno
Toshiro Yano
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of NO20041194L publication Critical patent/NO20041194L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO20041194A 2001-08-21 2004-03-19 Farmasoytiske preparater som omfatter polysakkaridkonjugater for inhibering av metastasen eller forhindring av nytt anfall av malign tumor NO20041194L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001249717 2001-08-21
PCT/JP2002/008309 WO2003015826A1 (fr) 2001-08-21 2002-08-16 Compositions pharmaceutiques comprenant des conjugues de polysaccharides permettant l'inhibition des metastases ou la prevention de la recurrence des tumeurs malignes

Publications (1)

Publication Number Publication Date
NO20041194L true NO20041194L (no) 2004-03-19

Family

ID=19078678

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041194A NO20041194L (no) 2001-08-21 2004-03-19 Farmasoytiske preparater som omfatter polysakkaridkonjugater for inhibering av metastasen eller forhindring av nytt anfall av malign tumor

Country Status (18)

Country Link
EP (1) EP1418947A1 (fr)
KR (1) KR20040027972A (fr)
CN (1) CN100372570C (fr)
AR (1) AR035137A1 (fr)
AU (1) AU2002328093B2 (fr)
BR (1) BR0212036A (fr)
CA (1) CA2457056C (fr)
HU (1) HUP0401351A3 (fr)
IL (1) IL160148A0 (fr)
MX (1) MXPA04001599A (fr)
NO (1) NO20041194L (fr)
NZ (1) NZ530947A (fr)
PL (1) PL368319A1 (fr)
RU (1) RU2275913C2 (fr)
TW (1) TWI313609B (fr)
UA (1) UA75450C2 (fr)
WO (1) WO2003015826A1 (fr)
ZA (1) ZA200400917B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306314A (en) * 2002-04-16 2003-11-16 Tanabe Seiyaku Co Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation
FR2914305B1 (fr) 2007-03-29 2009-07-03 Proteins & Peptides Man Dextran fonctionnalise par des amino-acides hydrophobes.
EP3693454A1 (fr) 2008-07-16 2020-08-12 Children's Medical Center Corporation Dispositif simulateur d'organe comportant des microcanaux et ses procédés d'utilisation et de fabrication
AU2012262139B2 (en) * 2011-06-02 2017-02-23 Children's Medical Center Corporation Methods and uses for ex vivo tissue culture systems
PL221351B1 (pl) 2012-03-14 2016-03-31 Politechnika Warszawska Sposób otrzymywania nanocząstek polisacharydowych
KR102087017B1 (ko) 2012-10-11 2020-03-10 다이이찌 산쿄 가부시키가이샤 항체-약물 콘주게이트
EP2910573B1 (fr) * 2012-10-19 2020-02-19 Daiichi Sankyo Company, Limited Conjugué anticorps-médicament produit par liaison par l'intermédiaire d'un lieur ayant une structure hydrophile
SG11201603960XA (en) 2014-01-31 2016-07-28 Daiichi Sankyo Co Ltd Anti-her2 antibody-drug conjugate
TWI718144B (zh) 2015-05-04 2021-02-11 美商輝瑞股份有限公司 B型鏈球菌多醣-蛋白質軛合物、製造軛合物之方法、含軛合物之免疫原性組成物、及其用途
BR112017027690A2 (pt) 2015-06-29 2018-10-09 Daiichi Sankyo Co Ltd “método para produção de uma composição de conjugado anticorpo-fármaco, e, composição de conjugado anticorpo-fármaco
EP3552626A4 (fr) 2016-12-12 2020-06-10 Daiichi Sankyo Company, Limited Association d'un conjugué anticorps-médicament et d'un inhibiteur de point de contrôle immunitaire
JP6679762B2 (ja) 2017-01-17 2020-04-15 第一三共株式会社 抗gpr20抗体及び抗gpr20抗体−薬物コンジュゲート
TW202330036A (zh) 2017-05-15 2023-08-01 日商第一三共股份有限公司 抗體-藥物結合物之製造方法
CN117838880A (zh) 2017-08-31 2024-04-09 第一三共株式会社 制备抗体-药物缀合物的新方法
EP3677589A4 (fr) 2017-08-31 2021-04-21 Daiichi Sankyo Company, Limited Procédé amélioré de production d'un conjugué anticorps-médicament
CN117815404A (zh) 2018-05-18 2024-04-05 第一三共株式会社 抗-muc1抗体-药物缀合物
CN109481691A (zh) * 2018-11-20 2019-03-19 珠海天香苑生物科技发展股份有限公司 吉西他滨-羧甲基多糖共轭物、制备方法及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0640622T3 (da) * 1993-02-26 2000-10-23 Drug Delivery System Inst Ltd Polysaccharidderivat og lægemiddelbærer
SG50747A1 (en) * 1995-08-02 1998-07-20 Tanabe Seiyaku Co Comptothecin derivatives
CA2192725C (fr) * 1995-12-28 2004-04-20 Kenji Tsujihara Derives de la camptothecine
WO1997038727A1 (fr) * 1996-04-15 1997-10-23 Asahi Kasei Kogyo Kabushiki Kaisha Composite medicamenteux
TW527183B (en) * 1996-06-06 2003-04-11 Daiichi Seiyaku Co Drug complex
CN1058038C (zh) * 1996-12-31 2000-11-01 中国科学院感光化学研究所 低收缩性光固化涂层材料及其制法和用途
EA003398B1 (ru) * 1998-05-22 2003-04-24 Дайити Фармасьютикал Ко., Лтд. Лекарственный комплекс c полимерным носителем

Also Published As

Publication number Publication date
CA2457056A1 (fr) 2003-02-27
ZA200400917B (en) 2004-08-25
RU2004108141A (ru) 2005-04-20
AU2002328093B2 (en) 2005-05-05
IL160148A0 (en) 2004-07-25
CN1545423A (zh) 2004-11-10
PL368319A1 (en) 2005-03-21
KR20040027972A (ko) 2004-04-01
CA2457056C (fr) 2008-07-22
TWI313609B (en) 2009-08-21
NZ530947A (en) 2006-04-28
BR0212036A (pt) 2004-08-17
CN100372570C (zh) 2008-03-05
MXPA04001599A (es) 2004-07-08
UA75450C2 (en) 2006-04-17
EP1418947A1 (fr) 2004-05-19
AR035137A1 (es) 2004-04-14
WO2003015826A1 (fr) 2003-02-27
RU2275913C2 (ru) 2006-05-10
HUP0401351A3 (en) 2011-02-28
HUP0401351A2 (hu) 2004-12-28

Similar Documents

Publication Publication Date Title
NO20041194L (no) Farmasoytiske preparater som omfatter polysakkaridkonjugater for inhibering av metastasen eller forhindring av nytt anfall av malign tumor
LTPA2019511I1 (lt) Rapamicino darinys, skirtas plaučių vėžio gydymui
CY2015003I1 (el) Φαρμακευτικες συνθεσεις για θεραπεια καρκινου
NO20024610D0 (no) Synergistiske metoder og blandinger for behandling av kreft
NO20020663L (no) NSAID og EFGR kinase inhibitor inneholdende sammensetning for behandling eller inhibisjon av tarmpolypper og tarmkreft
NO20033556D0 (no) Farmasöytiske preparater
NO20015222L (no) Forhindring av strömming gjennom undergrunnsområder
DE60207815D1 (de) 1-aryl-oder 1-alkylsulfonylbenzazol derivate als 5-hydroxytryptamin-6 liganden
NO20042035L (no) Forbedret anvendelse av antitumorforbindelse i kreftterapi
NO20015516D0 (no) Preparater og anvendelser av ET743 for behandling av kreft
NO20040516L (no) Kombinasjonsterapi for behandling av kreft.
NO20044916L (no) Preparater av sulfinylacetamid
NO20034780L (no) Antiangiogenisk kombinasjonsterapi for behandling av kreft
DE69805334D1 (de) Derivate des vitamin e
NO20000942D0 (no) Valg av nedihulls hydraulisk bane
EE200100061A (et) Migreeni kordumise ärahoimine
AU2002313426A1 (en) Tumor antigens for prevention and/or treatment of cancer
ITBZ20010003U1 (it) Dispositivo per la protezione di edifici da piene.
NO20034561D0 (no) Anvendelse av kationiske dekstranderivater for beskyttelse av dosebegrensende organer
FI20030393A (fi) Menetelmiä, joilla voidaan ennustaa rintasyövän kehistyskulku ja yhdisteitä, joita voidaan käyttää sen ehkäisemiseksi tai hoitamiseksi
AU2001214116A1 (en) Novel paclitaxel derivatives for the treatment of cancer
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
NO20012605A (no) Elektromagnetisk drift av rotorsystem
DE60232228D1 (de) Mammakarzinomdetektor
FI20011908A (fi) Menetelmä vatsasyövän osoittamiseksi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application